These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3136264)

  • 1. [Production of factor VIII deficient plasma by immunodepletion using monoclonal antibodies to vWF and to factor VIII, and its application].
    Nakai H; Shima M; Tanaka I; Fujiwara T; Terada S; Takase T; Yoshioka A; Fukui H
    Rinsho Byori; 1988 Apr; 36(4):475-80. PubMed ID: 3136264
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibodies against the human factor VIII von Willebrand molecule: characterization and potential for screening of von Willebrand patients.
    Avner P; Arnaud D; Sultan Y; Maisonneuve P; Jeanneau C
    Dev Biol Stand; 1984; 57():69-76. PubMed ID: 6084622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoaffinity purification of factor VIII complex.
    Hornsey VS; Griffin BD; Pepper DS; Micklem LR; Prowse CV
    Thromb Haemost; 1987 Feb; 57(1):102-5. PubMed ID: 3109055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Registry of monoclonal antibodies to factor VIII and von Willebrand factor. International Committee on Thrombosis and Haemostasis.
    Goodall AH; Meyer D
    Thromb Haemost; 1985 Dec; 54(4):878-91. PubMed ID: 3937279
    [No Abstract]   [Full Text] [Related]  

  • 5. [Monoclonal antibodies against human factor VIII and von Willebrand factor].
    Yoshioma A; Shima M
    Nihon Ketsueki Gakkai Zasshi; 1987 May; 50(3):681-7. PubMed ID: 3122486
    [No Abstract]   [Full Text] [Related]  

  • 6. Factor VIII/von Willebrand factor.
    Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1510-8. PubMed ID: 2451878
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical properties of Monoclate factor VIII:C antihemophilic factor (human) using monoclonal antibody to von Willebrand factor (VWF).
    Nilsson IM
    Semin Hematol; 1988 Apr; 25(2 Suppl 1):33-7. PubMed ID: 3133776
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunopurification of human factor VIII/vWF complex from plasma.
    Mejan O; Fert V; Delezay M; Delaage M; Cheballah R; Bourgois A
    Thromb Haemost; 1988 Jun; 59(3):364-71. PubMed ID: 3142074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of factor-VIII-depleted plasma with antibodies and its use for the assay of factor VIII.
    Rothschild C; Amiral J; Adam M; Meyer D
    Haemostasis; 1990; 20(6):321-8. PubMed ID: 2129163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
    Aihara M; Kimura A; Chiba Y; Yoshida Y
    Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of monoclonally-purified and recombinant factor VIII in patients with severe von Willebrand disease.
    Morfini M; Mannucci PM; Tenconi PM; Longo G; Mazzucconi MG; Rodeghiero F; Ciavarella N; De Rosa V; Arter A
    Thromb Haemost; 1993 Aug; 70(2):270-2. PubMed ID: 8236134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human factor VIII:C purified using monoclonal antibody to von Willebrand factor.
    Levine PH
    Semin Hematol; 1988 Apr; 25(2 Suppl 1):1-2. PubMed ID: 3133770
    [No Abstract]   [Full Text] [Related]  

  • 13. [Monoclonal antibodies against the factor VIII/Willebrand factor molecule: inhibition of the cofactor action of ristocetin and the antihemophilic factor].
    Sola B; Avner P; Sultan Y; Jeanneau C; Maisonneuve P
    C R Seances Acad Sci III; 1981 May; 292(18):1055-7. PubMed ID: 6790137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of human factor VIII from a heat-treated factor VIII concentrate in the presence of potent protease inhibitors.
    Shima M; Yoshioka A; Tanaka I; Fujiwara T; Nakai H; Tsubura Y; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1987 Sep; 50(6):1239-45. PubMed ID: 3120453
    [No Abstract]   [Full Text] [Related]  

  • 15. Altered serum factor VIII-related antigen (VIII : AGN)/von Willebrand factor (VIII : vWf) in haemophiliacs with inhibitors to factor VIII procoagulant activity (VIII : C).
    Ballard JO; Sanders JC; Eyster ME
    Thromb Haemost; 1981 Feb; 45(1):68-72. PubMed ID: 6166064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of factor VIII deficient plasma by immunodepletion using three monoclonal antibodies.
    Takase T; Rotblat F; Goodall AH; Kernoff PB; Middleton S; Chand S; Denson KW; Austen DE; Tuddenham EG
    Br J Haematol; 1987 Aug; 66(4):497-502. PubMed ID: 3117089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease.
    Girma JP; Pietu G; Lavergne JM; Meyer D; Larrieu MJ
    J Lab Clin Med; 1982 Apr; 99(4):481-94. PubMed ID: 6174657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttransfusion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor.
    Bergamaschini L; Mannucci PM; Federici AB; Coppola R; Guzzoni S; Agostoni A
    J Lab Clin Med; 1995 Mar; 125(3):348-55. PubMed ID: 7897302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the structure and function of factor VIII by monoclonal antibodies.
    Hada M; Yorifuji H; Arai M
    Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1681-8. PubMed ID: 3128935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.